Bhooth Bangla Eyes Bhool Bhulaiyaa’s Milestone: 57 Crores to Go

New Delhi, April 28, 2026: The return of the iconic director-actor duo, Priyadarshan and Akshay Kumar, has reignited the magic of the horror-comedy genre at the Indian box office. With Bhooth Bangla currently drawing massive crowds, fans and trade analysts alike are drawing parallels to the film that arguably defined the genre for the last two decades: the 2007 cult classic, Bhool Bhulaiyaa. As Bhooth Bangla continues its strong theatrical run, it finds itself closing in on a significant numerical milestone, standing just 57 crore away from matching the lifetime legacy of the 2007 blockbuster.

A Reunion Fueled by Nostalgia

Released on April 17, 2026, Bhooth Bangla was one of the most anticipated films of the year, marking the return of the Akshay Kumar-Priyadarshan pairing after a hiatus of nearly 16 years. Their previous collaborations—including Hera Pheri, Bhagam Bhag, and the legendary Bhool Bhulaiyaa—created a blueprint for comedy that has been hard to replicate.

In Bhooth Bangla, the team has successfully tapped into the same blend of supernatural intrigue and slapstick humor. The film’s opening was robust, crossing the ₹100 crore mark globally in just five days, proving that the audience’s appetite for this specific brand of “Priyadarshan-style” entertainment remains undiminished.

The Box Office Math: Bridging the Gap

The comparison between Bhooth Bangla and Bhool Bhulaiyaa is as much about cinema culture as it is about hard numbers. When Bhool Bhulaiyaa was released in 2007, it changed the landscape for horror-comedies in India. While inflation and the expansion of the cinema market mean that Bhooth Bangla is operating on a different scale of ticket pricing and screen counts, the milestone of matching the original’s lifetime box office collection remains a symbolic “passing of the torch.”

As of late April 2026, Bhooth Bangla has firmly established itself in the ₹100 crore club (net, domestic). With reports suggesting a steady hold at the box office and positive word-of-mouth driving footfalls into its second and third weeks, trade experts believe the film is well-positioned to hit the next major benchmark. The target—a total gross that aligns with the lifetime earnings of Bhool Bhulaiyaa—requires a final push of approximately ₹57 crore.

Why This Comparison Matters

For fans, this isn’t just about revenue; it’s about validation.

• Genre Authenticity: While modern horror-comedies often lean heavily into CGI-heavy spectacle, Bhooth Bangla is being praised for returning to the “old school” charm of character-driven comedy, where the humor is rooted in the eccentricities of the cast rather than just jump scares.
• The Akshay Factor: After a series of varied experiments in different genres, Bhooth Bangla proves that Akshay Kumar remains the undisputed king of the comedy-horror crossover. By revisiting the tone that made him a superstar in the mid-2000s, the actor has managed to reconnect with his core family audience.

The Road Ahead

While the film faced early competition from other major releases like Dhurandhar 2, it has shown remarkable resilience. The “57-crore gap” is not just a figure; it is a test of the film’s longevity. If Bhooth Bangla maintains its current momentum through the coming weeks, it won’t just be a successful film—it will cement itself as a spiritual successor to the Bhool Bhulaiyaa legacy.

For a generation of viewers who grew up watching the original Bhool Bhulaiyaa on repeat, seeing Akshay Kumar and Priyadarshan reclaim that magic is a victory in itself. Whether or not it eventually edges past the 2007 classic in absolute terms is secondary to the fact that the “Bhooth Bangla” brand has successfully carved out its own space in the horror-comedy universe.

As the film continues to track well across major territories—from Mumbai to Delhi-UP—the industry is watching closely. Can the Bhooth Bangla team close that 57-crore gap and officially enter the pantheon of Akshay Kumar’s highest-grossing classics? If the current trends are any indication, the answer is a resounding “yes.”